Jennifer Linder, RN-BSN, RNFA, CNOR | |
10217 Salem Way, Waco, TX 76708-6131 | |
(210) 748-0978 | |
Not Available |
Full Name | Jennifer Linder |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Perioperative |
Location | 10217 Salem Way, Waco, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285047613 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | K1462 (Texas) | Secondary |
364SP2800X | Clinical Nurse Specialist - Perioperative | 814313 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jennifer Linder, RN-BSN, RNFA, CNOR 10217 Salem Way, Waco, TX 76708 Ph: (210) 748-0978 | Jennifer Linder, RN-BSN, RNFA, CNOR 10217 Salem Way, Waco, TX 76708-6131 Ph: (210) 748-0978 |
News Archive
Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
Oberthur Technologies, the world's second largest provider of Smart Card based solutions, and Groupe Sephira, leading supplier of electronic claims for the French Healthcare Committee, jointly announce their attendance at the Salon CARTES et Identification which will take place in Paris, November 17-19, 2009.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
The Johns Hopkins Berman Institute of Bioethics has been received one of 50 pilot project awards by the Patient-Centered Outcomes Research Institute (PCORI) to study stakeholder views of streamlined informed consent options for comparative effectiveness research (CER) studies.
› Verified 4 days ago